pharma · Critical Limb Ischemia (CLI) · Sarcoma · DSGN
Lxo Ireland Designated
Lxo Ireland Designated Activity Company
Lxo Ireland Designated clinical programs — 30 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- CARLSBAD, CA, IE
- Programs
- 68
- Drugs
- 61
- Patents
- 201
Lxo Ireland Designated projects
30 ClinicalTrials.gov programs sponsored by Lxo Ireland Designated.
Lxo Ireland Designated has 30 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS
Lxo Ireland Designated Activity Company
Sars-CoV2
1 trial -
Adult Allogeneic Mesenchymal cells from adipose tissue.
Lxo Ireland Designated Activity Company
Acute Graft Versus Host Disease
1 trial -
Anterior lamellar nanostructured artificial human cornea.
Lxo Ireland Designated Activity Company
Severe Trophic Corneal Ulcers Refractory to Conventional Treatment
1 trial -
Autologous Bone Marrow Mononuclear Cells
Lxo Ireland Designated Activity Company
Peripheral Vascular Diseases
1 trial -
Autologous adipose derived mesenchymal stem cells
Lxo Ireland Designated Activity Company
Critical Limb Ischemia (CLI)
1 trial -
Autologous mesenchymal stem cells from adipose tissue.
Lxo Ireland Designated Activity Company
Autoimmune Diseases
1 trial -
Bioengineered Artificial Mesenchimal Sheet (BAMS)
Lxo Ireland Designated Activity Company
Venous Ulcer
1 trial -
Bone marrow mesenchymal stem cells autologous
Lxo Ireland Designated Activity Company
Multiple Sclerosis
1 trial -
Bone marrow mononuclear cells
Lxo Ireland Designated Activity Company
Chronic Myocardial Ischemia
1 trial -
CMB305
Lxo Ireland Designated Activity Company
Sarcoma
2 trials -
CMMo/RH/2009
Lxo Ireland Designated Activity Company
Liver Transplant Rejection
1 trial -
Combination of MK3475 with Metronomic CP
Lxo Ireland Designated Activity Company
Sarcoma
1 trial -
DT-168
Lxo Ireland Designated Activity Company
Fuchs Endothelial Corneal Dystrophy
1 trial -
DT-216P2
Lxo Ireland Designated Activity Company
Friedreich Ataxia
2 trials -
EudraCT: 2008-004014-27
Lxo Ireland Designated Activity Company
Graft Versus Host Disease
1 trial -
FIB-BIO-2023-03
Lxo Ireland Designated Activity Company
Cleft Lip and Palate
1 trial -
G100
Lxo Ireland Designated Activity Company
Follicular Low Grade Non-Hodgkin's Lymphoma
1 trial -
Gabapentin
Lxo Ireland Designated Activity Company
Sickle Cell Disease
1 trial -
Hyperimmune plasma
Lxo Ireland Designated Activity Company
SARS-CoV 2
1 trial -
IMD-1041
Lxo Ireland Designated Activity Company
Chronic Obstructive Pulmonary Disease
1 trial -
Infusion of MSC
Lxo Ireland Designated Activity Company
Discordant Immunological Response in HIV Infected Subjects
1 trial -
Infusion of autologous mononuclear bone marrow cells
Lxo Ireland Designated Activity Company
Idiopathic Dilated Cardiomyopathy
1 trial -
Infusion of mesenchymal stem cells from adipose tissue
Lxo Ireland Designated Activity Company
Faecal Incontinence
1 trial -
Injectable suspension of allogeneic adult mesenchymal stem cells
Lxo Ireland Designated Activity Company
Hidradenitis Suppurativa
1 trial -
Intraarterial infusion of autologous bone marrow cells
Lxo Ireland Designated Activity Company
Critical Limb Ischemia (CLI)
2 trials -
Intracoronary infusion of autologous bone marrow cells
Lxo Ireland Designated Activity Company
Dilated Cardiomyopathy
1 trial -
Intravenous administration of 1 million of MSC
Lxo Ireland Designated Activity Company
Amyotrophic Lateral Sclerosis
1 trial -
Mesenchymal stem cells from adipose tissue
Lxo Ireland Designated Activity Company
Critical Limb Ischemia
1 trial -
PHITAH
Lxo Ireland Designated Activity Company
Basal Cell Carcinoma
1 trial -
Stem cell infusion
Lxo Ireland Designated Activity Company
Critical Limb Ischemia (CLI)
1 trial
Frequently asked questions
How many clinical projects does Lxo Ireland Designated have?
30 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.